关于公司
APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies. Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Its goal is to create novel products to meet critical patient needs, including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
JP
未知
未验证公司
业务透明度
- 未验证公司信息
- 向他们的客户询问评论
- 没有回复负面评论